US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Michael S/ Lavery
Recent news which mentions Michael S/ Lavery
Piper Sandler Maintains Underweight On Canopy Growth Stock, Calls Cannabis Rescheduling 'Largely Symbolic'
May 31, 2024
Tickers
CGC
NEWS
Tags
cannabis stocks
Downgrades
Luke Maloney
From
Benzinga
From Underweight To Under Scrutiny: Can Canopy Growth Turn The Tide? Piper Sandler's Forecast On The Weed Giant
February 12, 2024
Tickers
CGC
CRLBF
GTBIF
NEWS
Tags
Analyst Ratings
Michael S/ Lavery
Canopy Growth Corp
From
Benzinga
Analysts Agree: Federal Cannabis Legalization Unlikely To Happen Soon, Does SAFE Act Have Better Chance This Year?
March 29, 2022
Tags
MORE act
Beacon Policy Advisors
Market News
From
Benzinga